 |
Oxis
International Inc.
323 Vintage
Park Drive, Suite B
Foster City,
CA 92202 USA
Tel:
650-212-2568
Toll free:
800-547-3686
FAX: 650-212-2569
e-mail: info@oxis.com
|
 |
| | | Testosterone Enzyme Immunoassay | | Catalog Number: 11150 | Enzyme Immunoassay for the Quantitative
Determination of Testosterone Concentration in Human Serum | **For research use only. Not for use in diagnostic procedures.**
| View Product Insert (Problems downloading insert? Click here)
| | Introduction: | Introduction: Testosterone (17?-hydroxyandrost-4-ene-3-one) is a C19 steroid with an unsaturated bond between C-4 and C-5, a ketone group in C-3 and a hydroxyl group in the ? position at C-17. This steroid hormone has a molecular weight of 288.4. Testosterone is the most important androgen secreted into the blood. In males, testosterone is secreted primarily by the Leydig cells of the testes; in females ca. 50% of circulating testosterone is derived from peripheral conversion of androstenedione, ca. 25% from the ovary and ca. 25% from the adrenal glands.
Testosterone is responsible for the development of secondary male sex characteristics and its measurements are helpful in evaluating the hypogonadal states. In women, high levels of testosterone are generally found in hirsutism and virilization, polycystic ovaries, ovarian tumors, adrenal tumors and adrenal hyperplasia. In men, high levels of testosterone are associated to the hypothalamic pituitary unit diseases, testicular tumors, congenital adrenal hyperplasia and prostate cancer. Low levels of testosterone can be found in patients with the following diseases: Hypopituitarism, Klinefelter?s syndrome, Testicular feminization, Orchidectomy and Cryptorchidism, enzymatic defects and some autoimmune diseases.
The Testosterone EIA kits are designed for the measurement of total Testosterone in human serum.
| | Application: | Clinical Application: (Information is cited from reference # 7)
In Male:
In man, the determination of testosterone is used as an indicator for
the function of the testes: low hormone levels are found in cases
with Klinefelter's syndrome, cryptorchism or anorchia. Male with
testosterone deficiency often present with a number of symptoms
such as decreased libido, as well as decreased muscle strength,
gynecomastia and infertility.
In Female:
- Virilizing Disorders:
Testosterone measurements are frequently utilized in the
evaluation of virilizing disorders. Testosterone
concentrations >2.0 ng/ml may indicate androgen
secreting ovarian or adrenal neoplasms.
- Monitoring of Androgen Suppressing Drugs:
Testosterone measurements may be utilized in women for
the adjustment of androgen suppressing drugs and their
dosages.
- Pregnancy:
Testosterone concentrations are relatively consistent
during the pregnancy.
| | Safety: | Test methods are not available which can offer complete assurance
that Hepatitis B virus, Human Immunodeficiency Virus (HIV/HTLVIII/
LAV), or other infectious agents are absent from the reagents in
this kit. Therefore, all human blood products, including patient
samples, should be considered potentially infectious. Handling and
disposal should be in accordance with the procedures defined by an
appropriate national biohazard safety guideline or regulation, where
it exists (e.g., USA Center for Disease Control/National Institute of
Health Manual,
| | Curve: | Results of a typical standard run with optical density readings at
450 nm shown in the Y axis against Testosterone concentrations
shown in the X axis. Note: This standard curve is for the purpose of
illustration only, and should not be used to calculate unknowns.
Each laboratory must provide its own data and standard curve in
each experiment.
| Testosterone (ng/ml) | Absorbance (450 nm) |
| 0 | 3.096 |
| 0.1 | 2.700 |
| 0.5 | 2.185 |
| 2.0 | 1.709 |
| 6.0 | 1.105 |
| 18.0 | 0.516 |
|
| | Sensitivity: | The minimum detectable concentration of the Oxis Testosterone ELISA assay as measured by 2 SD from the mean of a zero standard is estimated to be 0.05 ng/ml.
| | Performance: | Good laboratory practice requires that controls are run with each
calibration curve. A statistically significant number of controls
should be assayed to establish mean values and acceptable ranges
to assure proper performance.
We recommend using Bio-Rad Lyphochek Immunoassay Control
Sera as controls. The Testosterone EIA kit also provides with
internal controls, Level 1 and 2.
| | Storage: | Unopened test kits should be stored at 2-8 degrees C.
| | Kit Contents: | MATERIALS PROVIDED WITH THE KIT:
- Goat Anti-Rabbit IgG-coated microtiter wells, 96 wells
- Testosterone Reference Standards: 0, 0.1, 0.5, 2.0, 6.0 and
18.0 ng/ml. Liquids, 0.5 ml each, ready to use.
- Rabbit Anti-Testosterone Reagent (pink color), 7 ml
- Testosterone-HRP Conjugate Reagent (blue color), 12 ml
- Testosterone Control 1, Liquid, 0.5 ml, Ready to use.
- Testosterone Control 2, Liquid, 0.5 ml, Ready to use.
- TMB Reagent (One-Step) 11 ml.
- Stop Solution (1N HCl), 11 ml.
MATERIALS REQUIRED BUT NOT PROVIDED:
| | Instrumentation: | A microtiter plate reader with a bandwidth of 10 nm or less and an optical density range of 0-3 O.D. at 450 nm wavelength is
acceptable for use in absorbance measurement.
| | Assay Precision: | a. Intra-Assay Precision
Within-run precision was determined by replicate
determinations of four different serum samples in one
assay. Within-assay variability is shown below:
| Samples | 1 | 2 | 3 | 4 |
| # Replicates | 24 | 24 | 24 | 24 |
| Mean
Testosterone
(ng/ml) |
0.44 |
3.7 |
5.1 |
12.7 |
| S.D. | 0.03 | 0.4 | 0.4 | 0.6 |
| C.V. (%) | 6.4 | 10.0 | 8.3 | 5.0 |
|
b. Inter-Assay Precision
Between-run precision was determined by replicate
measurements of six different serum samples over a
series of individually calibrated assays. Between-assay
variability is shown below:
| Samples | 1 | 2 | 3 | 4 |
| # Replicates | 20 | 20 | 20 | 20 |
| Mean
Testosterone
(ng/ml) |
0.45 | 3.4 | 5.0 | 13.3 |
| S.D. | 0.02 | 0.3 | 0.2 | 0.5 |
| C.V. (%) | 4.4 | 8.4 | 4.4 | 3.7 |
|
| | References | View Product References
| |   |
|
|
|
|
|